Meeting objectives:
- provide an overview of the current viral hepatitis situation in the countries: surveillance systems, epidemiology, screening, burden, prevention, treatment and the cascade of care
- discuss achievements and challenges in the prevention and control of viral hepatitis, the possible implementation of new prevention strategies, control measures and monitoring system in the countries
- discuss the development and the implementation of a national hepatitis plans
- assess the needs to achieve the goal of eliminating viral hepatitis as a major public health threat by 2030 as set out in the renewed WHO Global Strategy and WHO Europe Action Plan, building on the UN Sustainable Development Goals’ (SDG) commitments
- discuss successes, issues and barriers to overcome and the way forward.
Background document (1.446 kB, pdf)
Thursday 27 October 2022
Session 1: Opening and objectives | |
Chairs: Greet Hendrickx & Milan Mishkovikj | |
08:30 – 09:00 |
Welcome and opening of the meeting Introduction of the participants Introduction of the VHPB Objectives of the meeting Review of the meeting programme
Welcome by Dr. Bekim Sali Minister of Health |
Session 2: The health care system in The Balkan countries | |
Chairs: Daniel Lavanchy & Angela Dominguez | |
09:00 – 10:30 |
Introduction in the health care system and infectious disease service of the different countries (focused on viral hepatitis) (following a VHPB slide template, 10 minutes/country) Bosnia-Herzegovina – Vesna Lucic-Samardzija / Azra Husic-Selimovic (pre-recorded) Montenegro – Aleksandra Marjanovic North Macedonia – Marija Dimzova Serbia – Violeta Rakic / Tomislav Preveden Croatia – Adriana Vince / Tatjana Nemeth Blažić
|
10:30 – 10:50 | Q&A |
10:50-11:10 | Coffee Break |
Session 3: Current viral hepatitis situation | |
Chairs: Marko Korenjak & Françoise Roudot-Thoraval | |
11:10 – 12:50 |
Current situation: Epidemiological Hepatitis situation, burden of disease; How screening and prevention/vaccination are organised & Cascade of care (following a VHPB slide template, 20 minutes/country) Bosnia-Herzegovina – Vesna Lucic-Samardzija / Azra Husic-Selimovic (pre-recorded)
|
12:50-13:50 | Lunch Break |
Chairs: Mira Kojouharova & Daniel Shouval | |
13:50-15:10 |
Continued – Current situation: Epidemiological Hepatitis situation, burden of disease; How screening and prevention/vaccination are organised & Cascade of care North Macedonia – Marija Dimzova Serbia – Violeta Rakic / Tomislav Preveden Croatia – Adriana Vince / Tatjana Nemeth Blažić
|
15:10-15:40 |
Overview of Hepatitis surveillance and Epidemiology in Europe: Hepatitis B and C in EU/EEA countries and overview for Balkan countries
|
15:40-16:00 | Coffee Break |
Session 4: Literature session | |
Chairs: Silvia Bino | |
16:00 – 16:40 |
Role of the patient organisations in the Balkan region. Milan Mishkovikj (Hepar Centar Bitola)
|
16:40-17:20 |
Hepatitis B & C management policies in European and Balkan countries
|
17:20 – 17:40 | Q&A |
Friday 28 October 2022
Session 5: Elimination of viral hepatitis in Balkan region – Lessons learnt, best practices and future challenges | |
Chairs: Mojca Maticic & Thomas Vanwolleghem | |
8:30-8:50 |
Welcome by Dr. Ana Daneva Markova Health Advisor of the Prime Minister
WHO Global Strategy and the European action plan for viral hepatitis elimination, including WHO/Europe good practices Nicole Seguy – WHO Regional Office for Europe
|
8:50-9:00 | Q&A |
9:00-11:15 |
Presentations of best practices and issues to achieve the elimination goals (15 minutes/country) Bosnia-Herzegovina – Vesna Lucic-Samardzija / Azra Husic-Selimovic (pre-recorded) Montenegro – Aleksandra Marjanovic North Macedonia – Todorovska Beti / Kalina Stardelova Serbia – Violeta Rakic / Tomislav Preveden Croatia – Adriana Vince / Tatjana Nemeth Blažić
|
11:15-11:30 | Q&A |
11:30-11:50 | Coffee Break |
Session 6: Groups discussion – What are the needs to Eliminate viral hepatitis by 2030 | |
Chairs: Tatjana Reic | |
11:50-13:10 |
Group 1 – Epidemiological surveillance, screening, monitoring and analysis of the Group 2 -Prevention of viral hepatitis: improvement of vaccine prevention programs, prevention in high-risk groups, prevention in health care settings (Marcelo Naveira) Group 3 – Treatment of viral hepatitis: recommendations based on epidemiology and disease burden data, increasing access to treatment, coverage of the most affected groups (Senad Handanagic) |
13:10-13:30 | Presentation outcome of the groups sessions |
13:30-14:30 | Lunch Break |
Session 7: Conclusion of the meeting | |
Chairs: Marko Korenjak & Silvia Bino | |
14:30-15:15 |
Conclusion of the meeting, final discussion & closing of the meeting |
Meeting report (387 kB, Pdf) by David FitzSimons.